Coloplast As Stock Analysis

Coloplast Pink Sheet Analysis Notes

About 35.0% of the company shares are held by company insiders. The company last dividend was issued on the 2nd of December 2022. Coloplast A/S had 5:1 split on the 19th of December 2012. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.The quote for Coloplast AS is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Coloplast AS please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.

Coloplast A/S Investment Alerts

Coloplast Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 24.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast A/S's market, we take the total number of its shares issued and multiply it by Coloplast A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Coloplast Profitablity

The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.3 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.3.

Technical Drivers

As of the 9th of February, Coloplast A/S shows the Mean Deviation of 1.47, risk adjusted performance of (0.04), and Standard Deviation of 2.52. Coloplast A/S technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Coloplast A/S standard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Coloplast A/S is priced correctly, providing market reflects its regular price of 80.0 per share. Given that Coloplast A/S has information ratio of (0.1), we suggest you to validate Coloplast AS's prevailing market performance to make sure the company can sustain itself at a future point.

Coloplast A/S Price Movement Analysis

Coloplast A/S Predictive Daily Indicators

Coloplast A/S Forecast Models

Coloplast A/S's time-series forecasting models are one of many Coloplast A/S's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coloplast A/S's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Coloplast A/S Debt to Cash Allocation

Coloplast AS has accumulated 16.36 B in total debt with debt to equity ratio (D/E) of 2.83, implying the company greatly relies on financing operations through barrowing. Coloplast A/S has a current ratio of 0.99, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Coloplast A/S until it has trouble settling it off, either with new capital or with free cash flow. So, Coloplast A/S's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Coloplast A/S sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Coloplast to invest in growth at high rates of return. When we think about Coloplast A/S's use of debt, we should always consider it together with cash and equity.

Coloplast A/S Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Coloplast A/S's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Coloplast A/S, which in turn will lower the firm's financial flexibility.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Coloplast A/S prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Coloplast shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Coloplast A/S. By using and applying Coloplast Pink Sheet analysis, traders can create a robust methodology for identifying Coloplast entry and exit points for their positions.

When running Coloplast A/S's price analysis, check to measure Coloplast A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast A/S is operating at the current time. Most of Coloplast A/S's value examination focuses on studying past and present price action to predict the probability of Coloplast A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast A/S's price. Additionally, you may evaluate how the addition of Coloplast A/S to your portfolios can decrease your overall portfolio volatility.